|
Rosuvastatin 20 Mg Oral Tablet Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Crestor
Pipeline
Phase 3: 1
Top Sponsors
- Duke University1
Indications
- Prevention & Control1
- Coronary Artery Disease Risk Factors Multiple1
- Premature Atherosclerosis1
- Coronary Artery Disease Progression1
- Heart Disease1
Birmingham, Alabama1 trial
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
University of Alabama at Birmingham
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.